Market revenue in 2022 | USD 114.5 million |
Market revenue in 2030 | USD 215.8 million |
Growth rate | 8.2% (CAGR from 2022 to 2030) |
Largest segment | Biological skin substitutes |
Fastest growing segment | Biological Skin Substitutes |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biological Skin Substitutes, Topical Agents, Collagen Dressing Dressing |
Key market players worldwide | Molnlycke Health Care, Osiris Corp, Integra LifeSciences, Stryker Corp, Smith & Nephew PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to wound biologics market will help companies and investors design strategic landscapes.
Biological skin substitutes was the largest segment with a revenue share of 48.12% in 2022. Horizon Databook has segmented the China wound biologics market based on biological skin substitutes, topical agents, collagen dressing dressing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China wound biologics market , including forecasts for subscribers. This country databook contains high-level insights into China wound biologics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account